Santen Pharmaceutical Co., Ltd. held its 101st Annual General Meeting of Shareholders for the fiscal year 2012 on June 25, 2013. The Meeting started at 10:00 a.m. and ended at 10:36 a.m. The number of shareholders attended was 233.

 

Matters reported	Business Report, Consolidated Financial Statements and Non-consolidated Financial Statements for the 101st Business Term (April 1, 2012 to March 31, 2013) Independent Auditors Report and Corporate Auditors Report on the consolidated Financial Statements for the 101st Business Term (April 1, 2012 to March 31, 2013)
Questions	We received questions regarding the following subjects from three shareholders and responded in kind. The effects of exchange rate circumstances on business performance Causes of the reduced revenue experienced by U.S. operations The ratio between the sales of OTC and prescription pharmaceuticals Pharmaceutical sales over the Internets
Matters resolved	Four items of business as described below were all resolved. Resolution (PDF: 19KB)PDF file.Page will open in a new window.
Questions	There was no question submitted by shareholders.